BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26002815)

  • 1. (99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis.
    Galat A; Van Der Gucht A; Colombat M; Attias D; Itti E; Meignan M; Lebras F; Molinier-Frenkel V; Benhaiem N; Guellich A; Rosso J; Damy T
    J Nucl Cardiol; 2015 Aug; 22(4):853-7. PubMed ID: 26002815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
    Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Phase
    Galat A; Van der Gucht A; Guellich A; Bodez D; Cottereau AS; Guendouz S; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T; Rosso J
    JACC Cardiovasc Imaging; 2017 May; 10(5):601-603. PubMed ID: 27424245
    [No Abstract]   [Full Text] [Related]  

  • 5. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
    Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F
    J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-phase myocardial uptake intensity of
    Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apical sparing pattern of left ventricular myocardial
    Van Der Gucht A; Cottereau AS; Abulizi M; Guellich A; Blanc-Durand P; Israel JM; Galat A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Dec; 25(6):2072-2079. PubMed ID: 28447284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
    de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report.
    Zeng Y; Poterucha TJ; Einstein AJ; Zhang Q; Chen Y; Xie H; Wan K; Liang Y; Chen J; Tang G
    Medicine (Baltimore); 2021 Apr; 100(17):e25582. PubMed ID: 33907108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
    Bravo PE; Dorbala S
    Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation.
    Kobayashi T; Sekiya M; Fujiwara Y; Sumimoto T; Matsuoka H; Hamada M; Hiwada K
    Ann Nucl Med; 1993 Nov; 7(4):273-6. PubMed ID: 8292455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients.
    Monfort A; Rivas A; Banydeen R; Inamo J; Farid K; Neviere R
    Respir Res; 2022 Mar; 23(1):72. PubMed ID: 35346209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy.
    Gallini C; Tutino F; Martone R; Ciaccio A; Costanzo EN; Taborchi G; Morini S; Bartolini S; Farsetti S; Di Mario C; Perfetto F; Cappelli F
    J Nucl Cardiol; 2021 Feb; 28(1):90-99. PubMed ID: 30767162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis.
    Waheed A; Dorbala S
    Cardiol Clin; 2023 May; 41(2):217-231. PubMed ID: 37003679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.